SGLT2 inhibitors: a therapy for everybody but not for anything?

Publisher: Oxford University Press Country of Publication: England NLM ID: 101564430 Publication Model: Print Cited Medium: Internet ISSN: 2047-4881 (Electronic) Linking ISSN: 20474873 NLM ISO Abbreviation: Eur J Prev Cardiol Subsets: MEDLINE

Publication: 2021- : [Oxford] : Oxford University Press
Original Publication: London : Sage

Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Diabetes Mellitus, Type 2*/drug therapy; Humans ; Cardiovascular Diseases/drug therapy ; Treatment Outcome ; Blood Glucose/drug effects ; Blood Glucose/metabolism ; Hypoglycemic Agents/therapeutic use

Competing Interests: Conflict of interest: none declared.

Comment on: Eur J Prev Cardiol. 2024 May 11;31(7):770-779. doi: 10.1093/eurjpc/zwad356. (PMID: 37966828)

0 (Sodium-Glucose Transporter 2 Inhibitors)
0 (Blood Glucose)
0 (Hypoglycemic Agents)

Date Created: 20231206 Date Completed: 20240511 Latest Revision: 20240701

20240702

10.1093/eurjpc/zwad372

38057154